Anna Believantseva
Co-founder & COO at Esper Bionics
How to scale a healthtech product in the US market: Esper Bionics’ lessons learned
Latest news
Editor's pick
Related posts
Explore more
Making sense of private tech company valuations
Private tech company valuations are tricky. This article explains why equity value is so hard to pin down — especially for founders, employees, and early investors.
What European founders need to know about entering the US market: VC advice
How to expand successfully to the US and avoid common mistakes? Check out practical insights from GapMinder VC, Earlybird, Eleven Ventures, Rockaway Ventures, and PortfoLion.
Pitching for the first time? Avoid these 13 mistakes
Backer of Reface, Oura, Pipe; co-founder and GP of Roosh Ventures shares the 13 most common mistakes founders make when pitching — and how to fix them.
Latest news
Explore more
Austria's startup Ketryx raises $39M to modernize AI compliance for life sciences
Ketryx's $39 million Series B funding round was led by Transformation Capital, with participation from Lightspeed Venture Partners and 53 Stations
London-based firm Throxy secures $6.2M to revolutionize outbound sales in hard-to-reach industries
The seed round was led by Base10 Partners, with support from Y Combinator.
German ground autonomy platform FERNRIDE raises €18M to enter defence logistics
FERNRIDE’s funding round is backed by Helantic and Thomas Müller.